CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway

Table 3 Univariate and multivariate Cox regression analysis

Clinical variables	Univariate analysis		P	Multivariate analysis		P
Clinical variables	HR 95%CI		P	HR 95%CI		P
Age (≥ 50 vs. < 50)	1.550	0.917–2.621	0.102
Grade (I–II vs. III)	1.814	1.016–3.238	0.044	1.694	0.937–3.016	0.081
T stage (T1 vs. T2/3)	1.591	0.880–2.875	0.124
N stage (N0 vs. N1-3)	1.754	1.049–2.993	0.032	1.268	0.608–2.645	0.527
TNM stage (I–II vs. III)	2.295	1.405–3.746	0.001	1.542	0.759–3.133	0.231
circRNA (low vs. high)	3.342	1.746–6.399	0.000	2.868	1.476–5.570	0.002

ISSN: 1479-5876